Press Releases

20 Jun 2013

bioMérieux receives CE marking for VIDAS® 3, the new generation of VIDAS®

Marcy l'Étoile, France, June 20, 2013 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, has been granted CE marking. This instru...

30 May 2013

bioMérieux Receives FDA Approval for THxIDTM-BRAF Companion Diagnostic Test

The only CE-marked and FDA-approved BRAF test able to simultaneously detect 2 BRAF mutations, V600E and V600K providing high medical value information to select treatment for metastatic melanoma patie...

21 May 2013

Nicolas Cartier appointed Corporate Vice President, Industrial Microbiology Unit of bioMérieux

Marcy l’Etoile, France, May 21, 2013 — A major player in the field of in vitro diagnostics and world leader in industrial microbiology, bioMérieux has announced the appointment of Nicolas Cartier as C...

23 Apr 2013

bioMérieux - First-Quarter 2013 Business Review

Stable sales in a persistently difficult European economy 2013 objective of 3-5% organic sales growth maintained Solid commercial negotiations underway Confirmed favorable growth prospects in emerging...

25 Mar 2013

Veolia Environnement and bioMérieux initiate a research partnership to develop an innovative monitoring system for drinking water quality

Paris, Lyon, March 25, 2013 – At BIOVISION, the world life sciences forum, Veolia Environnement, global leader in water services and expert in environmental services, and bioMérieux, global player in ...

13 Mar 2013

biomerieux-2012-financial-results

2012 performance: objectives met Sales up 6.8% at constant exchange rates €260 million in operating income before non-recurring items €134 million in free cash flow Robust international expansion, par...

23 Jan 2013

2012 Business Review & Investor Day

2012 Business Review Sales up 6.8% at constant exchange rates, in line with targets for the year Investor Day Innovation and commercial strategy to drive competitiveness...

04 Dec 2012

bioMérieux Opens a Subsidiary in Vietnam, Strengthening its Footprint in High-growth Southeast Asia

Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, announces the opening of its 41st commercial subsidiary in Hanoi, Vietnam. This wholly owned company in Vietna...

15 Nov 2012

bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays

Quanterix’s Simoa™ technology to be developed for diagnostic applications. bioMérieux gains exclusive rights for clinical laboratories and industrial applications. bioMérieux takes equity stake in Qua...

07 Nov 2012

VIDAS® 3, the New-generation VIDAS®

VIDAS® 3, the New-generation VIDAS® Presented at the JIB International Biologists Congress...

31 Oct 2012

Dr. Mark Miller joins bioMérieux as Chief Medical Officer

World-leading expert on infectious disease prevention and control to enhance medical value of bioMérieux’s solutions...

23 Oct 2012

bioMérieux - Business Review for the nine months ended September 30, 2012

Sales Up 7.5% at constant exchange rates Of which 3.2%* organic growth Confirmed strong momentum in emerging markets 28% of consolidated sales 17%* organic growth...

09 Oct 2012